Nano-X Imaging Shares Rise After FDA Clearance for X-Ray System

Dow Jones12-05
 

By Chris Wack

 

Nano-X Imaging shares rose after the company received 510(k) clearance from the Food and Drug Administration for its Nanox.ARC, a stationary X-ray system intended for adult patients.

Shares were up 10% to $6.90 in recent trading. The stock is up almost 7% this year.

The medical imaging technology company said its Nanox.ARC uses advanced tomosynthesis technology to create a more comprehensive, sliced three-dimensional view of the body.

The Israeli company believes the new FDA-cleared indications will help broaden Nanox. ARC's commercial expansion in the U.S., where it is currently deployed in seven states.

 

Write to Chris Wack at chris.wack@wsj.com

 

(END) Dow Jones Newswires

December 05, 2024 10:48 ET (15:48 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment